Why is it so hard to get drugs approved for use during pregnancy?
Nobody wants to see another Thalidomide tragedy.
Sep 17, 2024
0
0
Heterocyclic Compounds: News and Research on Phthalimides
MeSH tree: D03.633.100.513.750
Public health errors: Why it's crucial to understand what they are before assessing COVID-19 responses
Joe Vipond, a Canadian emergency room physician who was a strong supporter of masking during the pandemic, said in a speech last year that the slow recognition that COVID-19 is spread by airborne transmission resulted in ...
Dec 5, 2023
0
0
Supplement lowers risk of higher glucose caused by blood-pressure drug, researchers find
A dietary supplement developed by a UT Southwestern Medical Center researcher significantly reduced high blood sugar caused by a diuretic used to lower blood pressure while also correcting electrolyte imbalances, UTSW researchers ...
Nov 30, 2023
0
3
Thalidomide cuts recurrent bleeding in small-intestinal angiodysplasia, finds study
For patients with recurrent bleeding due to small-intestinal angiodysplasia (SIA), thalidomide treatment results in a reduction in bleeding, according to a study published in the Nov. 2 issue of the New England Journal of ...
Nov 2, 2023
0
1
Tolerable treatments lacking for higher-risk myelodysplastic syndromes
There is a clear, unmet need for tolerable treatments that can produce durable remission among patients with higher-risk myelodysplastic syndromes (HR-MDS), according to a study published online Sept. 7 in Leukemia & Lymphoma.
Oct 20, 2023
0
0
Immune system plays vital role in longer multiple myeloma remission, new study shows
A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and other top-tier cancer centers highlights the vital role that the immune system plays in determining ...
Sep 6, 2023
0
48
Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer
Results of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show that adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) ...
Sep 1, 2023
0
0
Science experiments traditionally only used male mice. Here's why that's a problem for women's health
If you have ever taken a medicine, then you have benefited from research in animals. But ten years ago, if you looked at a scientific report involving mice or rats, it would probably have used only male animals.
Aug 15, 2023
0
1
CRISPR studies identify many promising therapeutic targets for multiple myeloma
New research from Dana-Farber Cancer Institute has identified 116 genes as key molecular vulnerabilities for multiple myeloma. Most of these genes are potential leads for the discovery of new therapies for this disease. The ...
May 29, 2023
0
94
Genetic test can guide treatment for blood cancer to prevent relapse
Scientists have found a new way to predict which patients with the blood cancer myeloma will benefit the most from a treatment often used to help keep the disease from coming back after a stem cell transplant.
Mar 20, 2023
0
15
